123 related articles for article (PubMed ID: 32604426)
1. The ABO Locus is Associated with Increased Fibrin Network Formation in Patients with Stable Coronary Artery Disease.
Winther-Larsen A; Christiansen MK; Larsen SB; Nyegaard M; Neergaard-Petersen S; Ajjan RA; Würtz M; Grove EL; Jensen HK; Kristensen SD; Hvas AM
Thromb Haemost; 2020 Sep; 120(9):1248-1256. PubMed ID: 32604426
[TBL] [Abstract][Full Text] [Related]
2. The ABO locus is associated with increased platelet aggregation in patients with stable coronary artery disease.
Christiansen MK; Larsen SB; Nyegaard M; Neergaard-Petersen S; Würtz M; Grove EL; Hvas AM; Jensen HK; Kristensen SD
Int J Cardiol; 2019 Jul; 286():152-158. PubMed ID: 30837090
[TBL] [Abstract][Full Text] [Related]
3. Imbalance between Fibrin Clot Formation and Fibrinolysis Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
Neergaard-Petersen S; Larsen SB; Grove EL; Kristensen SD; Ajjan RA; Hvas AM
Thromb Haemost; 2020 Jan; 120(1):75-82. PubMed ID: 31733633
[TBL] [Abstract][Full Text] [Related]
4. Fibrin clot structure and platelet aggregation in patients with aspirin treatment failure.
Neergaard-Petersen S; Ajjan R; Hvas AM; Hess K; Larsen SB; Kristensen SD; Grove EL
PLoS One; 2013; 8(8):e71150. PubMed ID: 23976993
[TBL] [Abstract][Full Text] [Related]
5. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies.
Reilly MP; Li M; He J; Ferguson JF; Stylianou IM; Mehta NN; Burnett MS; Devaney JM; Knouff CW; Thompson JR; Horne BD; Stewart AF; Assimes TL; Wild PS; Allayee H; Nitschke PL; Patel RS; ; ; Martinelli N; Girelli D; Quyyumi AA; Anderson JL; Erdmann J; Hall AS; Schunkert H; Quertermous T; Blankenberg S; Hazen SL; Roberts R; Kathiresan S; Samani NJ; Epstein SE; Rader DJ
Lancet; 2011 Jan; 377(9763):383-92. PubMed ID: 21239051
[TBL] [Abstract][Full Text] [Related]
6. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
[TBL] [Abstract][Full Text] [Related]
7. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
[TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
[TBL] [Abstract][Full Text] [Related]
9. The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk.
Tragante V; Doevendans PA; Nathoe HM; van der Graaf Y; Spiering W; Algra A; de Borst GJ; de Bakker PI; Asselbergs FW;
Eur Heart J; 2013 Oct; 34(37):2896-904. PubMed ID: 23828831
[TBL] [Abstract][Full Text] [Related]
10. Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics Study.
Wauters E; Carruthers KF; Buysschaert I; Dunbar DR; Peuteman G; Belmans A; Budaj A; Van de Werf F; Lambrechts D; Fox KA
Eur Heart J; 2013 Apr; 34(13):993-1001. PubMed ID: 23161703
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease.
Bochenek M; Zalewski J; Sadowski J; Undas A
J Thromb Thrombolysis; 2013 Feb; 35(2):264-70. PubMed ID: 23086579
[TBL] [Abstract][Full Text] [Related]
12. Genetic regulation of serum phytosterol levels and risk of coronary artery disease.
Teupser D; Baber R; Ceglarek U; Scholz M; Illig T; Gieger C; Holdt LM; Leichtle A; Greiser KH; Huster D; Linsel-Nitschke P; Schäfer A; Braund PS; Tiret L; Stark K; Raaz-Schrauder D; Fiedler GM; Wilfert W; Beutner F; Gielen S; Grosshennig A; König IR; Lichtner P; Heid IM; Kluttig A; El Mokhtari NE; Rubin D; Ekici AB; Reis A; Garlichs CD; Hall AS; Matthes G; Wittekind C; Hengstenberg C; Cambien F; Schreiber S; Werdan K; Meitinger T; Loeffler M; Samani NJ; Erdmann J; Wichmann HE; Schunkert H; Thiery J
Circ Cardiovasc Genet; 2010 Aug; 3(4):331-9. PubMed ID: 20529992
[TBL] [Abstract][Full Text] [Related]
13. Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy.
Sumaya W; Wallentin L; James SK; Siegbahn A; Gabrysch K; Bertilsson M; Himmelmann A; Ajjan RA; Storey RF
Eur Heart J; 2018 Apr; 39(13):1078-1085. PubMed ID: 29390064
[TBL] [Abstract][Full Text] [Related]
14. A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals.
Krarup NT; Borglykke A; Allin KH; Sandholt CH; Justesen JM; Andersson EA; Grarup N; Jørgensen T; Pedersen O; Hansen T
Atherosclerosis; 2015 Jun; 240(2):305-10. PubMed ID: 25864160
[TBL] [Abstract][Full Text] [Related]
15. Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein.
Szułdrzyński K; Jankowski M; Potaczek DP; Undas A
Dis Markers; 2020; 2020():7190828. PubMed ID: 32076463
[TBL] [Abstract][Full Text] [Related]
16. ABO locus O1 allele and risk of myocardial infarction.
von Beckerath N; Koch W; Mehilli J; Gorchakova O; Braun S; Schömig A; Kastrati A
Blood Coagul Fibrinolysis; 2004 Jan; 15(1):61-7. PubMed ID: 15166945
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of clot density, fibrin fiber radius, and protofibril packing in acute phase myocardial infarction.
Siniarski A; Baker SR; Duval C; Malinowski KP; Gajos G; Nessler J; Ariëns RAS
Thromb Res; 2021 Sep; 205():110-119. PubMed ID: 34298252
[TBL] [Abstract][Full Text] [Related]
18. The complexity of ABO in coronary heart disease.
Dahabreh IJ; Kitsios GD; Trikalinos TA; Kent DM
Lancet; 2011 Apr; 377(9776):1493; author reply 1493-4. PubMed ID: 21531266
[No Abstract] [Full Text] [Related]
19. A genome-wide association study reveals susceptibility loci for myocardial infarction/coronary artery disease in Saudi Arabs.
Wakil SM; Ram R; Muiya NP; Mehta M; Andres E; Mazhar N; Baz B; Hagos S; Alshahid M; Meyer BF; Morahan G; Dzimiri N
Atherosclerosis; 2016 Feb; 245():62-70. PubMed ID: 26708285
[TBL] [Abstract][Full Text] [Related]
20. Genetics of type 2 diabetes and coronary artery disease and their associations with twelve cardiometabolic traits in the United Arab Emirates population.
Osman W; Hassoun A; Jelinek HF; Almahmeed W; Afandi B; Tay GK; Alsafar H
Gene; 2020 Aug; 750():144722. PubMed ID: 32360841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
